Neuro-oncology advances, 2632-2498


Related Publications
  1. EGFR mutations are associated with response to depatux-m in combination with temozolomide and result in a receptor that is hypersensitive to ligand

    Hoogstrate, Y., Vallentgoed, W., Kros, J. M., de Heer, I., de Wit, M., Eoli, M., Sepulveda, J. M., Walenkamp, A. M. E., Frenel, J-S., Franceschi, E., Clement, P. M., Weller, M., van Royen, M. E., Ansell, P., Looman, J., Bain, E., Morfouace, M., Gorlia, T., Golfinopoulos, V., van den Bent, M. & French, P. J., 10-Jul-2020, In : Neuro-oncology advances. 2, 1

    Research output: Contribution to journalArticleAcademicpeer-review

View all (1) »

ID: 134206101